Cutting edge partnership

Singhe Hospitals, a multispecialty service healthcare provider based in Ratnapura District, will partner with Credence to deliver to both its inpatients as well as outpatients, Credence's cutting edge diagnostic tests, which can be used to predict, diagnose and treat patients with a variety of conditions.

Credence is Sri Lanka's pioneer in offering next generation sequencing services. Being a leader in clinical genomics, Credence provides tests to diagnose infections with over 95% sensitivity and specificity in half the time. Its unique portfolio of tests also caters to predicting and diagnosing cancer, especially of the breast and colorectal, which are the most common forms of inherited cancers in Sri Lanka. Credence genomics also is the only organisation in Sri Lanka to offer precision medicine tests for chemotherapy used in cancer.

Dr. Sunil Navaratnaraja, Director - Laboratories of Singhe Hospitals (Pvt) Ltd said, "Singhe Hospitals is a PLC hospital striving to expand its laboratory services to the entire country and this collaboration will further enhance our services in our endeavour to provide world class diagnostic services to Sri Lankans."

CEO/ Director of Credence Genomics, Dr. Vaz Gnanam said, "As genomic diagnostics comes into the forefront of healthcare diagnostics, our specialised tests help both physicians and patients alike by diagnosing with extreme accuracy. The partnership with Singhe Hospitals will cater to Singhe's expanding patient reach and provide them with extremely accurate and cutting edge diagnostic tests ".